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It has been more than a decade since it was proposed that non-fibrillar forms of amyloid-
β (Aβ) may play important role in Alzheimer’s disease (AD). Soluble Aβ dimers have 
been detected in the extract of Alzheimer’s human brains, indicating that Aβ dimer may be 
the basic building block of AD that associated with synaptotoxic species.(O’Nuallain et al., 
2010) For this reason, information about the structural details and properties of Aβ dimers 
are of great interest. Here we study the aggregation properties and conformational details 
of Aβ  monomer and two Aβ dimers: Aβ (M1-40) containing Cys in place of Ser-26, 
producing a disulfide cross-linked dimer, called [Aβ (M1-40)S26C]2; and Aβ (M1-40), 
which has a covalent bond at the side chain of Tyr-10, called [Aβ (M1-40)]tyr. Our data 
show that these three species aggregate at different rates, and form fibrillation products 
with different morphologies. NMR measurements demonstrate that the three Aβ (M1-40) 
species are fully disordered and show minimal differences in structural propensities, and 






























Alzheimer’s disease (AD) is the most common form of human dementia. It is a progressive 
brain disorder that slowly destroys memory and cognitive skills that can eventually be 
lethal (Shankar and Walsh, 2009). The end-stage of the AD brain is characterized by the 
decline of hippocampal formation and cerebral cortex and ventricular enlargement (see 
Figure 4. 1). It has been shown that amyloid plaques and neurofibrillary tangles (NFT) are 
detected throughout the hippocampus and cerebral cortex. The principle component of 
NFT is the microtubule-associated protein tau whereas amyloid plaques mainly contain 
Amyloid β-peptide (Aβ) (Walsh et al., 2005).  
 
 
Figure 4.1. The comparison of brain of a normal person (left) and the brain of person who suffers 
from Alzheimer’s disease (adapted from Wikipedia) 
 
Aβ is a peptide of 36-43 amino acids, processed from the β-amyloid precursor protein 
(APP) by the action of two aspartyl proteases called β- and γ- secretase, respectively 
(Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992). APP is an integral membrane 
protein expressed in many tissues and concentrated in the synapses of neurons.  This 
protein is first cleaved by β-secretase, leading to a 99 amino acid C-terminal fragment. 








Figure 4.2 Processing of β-amyloid precursor protein (APP) by β- and γ- secretases, producing the 
Aβ peptide. Several mutations that occur in APP are indicated. Adapted with permission from 
(Walsh and Selkoe, 2007)). Copyright Wiley-VCH Verlag GmbH &kGaA 
 
Depending on the exact point of cleavage by γ-secretase, there are 3 principal forms of Aβ, 
consisting of 38, 40, or 42 amino acid residues. Aβ peptide is present in the brains and 
cerebrospinal fluid (CSF) of normal humans during their entire life. The production of 
small numbers of Aβ peptide does not cause neurodegeneration, but the over-expression of 
all Aβ or an increase of 42-amino acid form, appears to cause early onset AD (Walsh and 
Selkoe, 2007). For this reason, Aβ peptide is believed to play an important role in 
Alzheimer’s disease (Walsh and Selkoe, 2007).  
 
Several facts support the idea of a causative role for Aβ in AD. For example (1) Synthetic 
Aβ peptides are toxic to hippocampal and cortical neurons, in vivo and in vitro. (2) 
Inherited mutations in the APP gene that occur within the Aβ region change the 
aggregation properties of Aβ and are sufficient to cause early-onset AD, a dementia 
developing before age 65 (Walsh and Selkoe, 2007).  
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Like several other disease-associated proteins, Aβ has the ability to self-associate and form 
different assembly forms (including dimers, trimers, tetramers, nonamers)(McLean et al., 
1999). Some studies have shown that neuronal injury appears as a result of Aβ self-
association (Busciglio et al., 1992; Geula et al., 1998; Pike et al., 1991). Initially, it was 
believed that amyloid plaques are related to toxicity.  However, in human brain the amount 
of amyloid plaque does not correlate with the severity of dementia (Katzman, 1986; Terry 
et al., 1991). Several studies have demonstrated a strong correlation between soluble Aβ 
levels and the extent of synaptic loss and severity of cognitive impairment (Lue et al., 
1999; Wang et al., 1999). Kuo et al isolated a range of non-fibrillar forms of Aβ  both 
from AD and healthy human brain using aqueous buffer (Kuo et al., 1990). In addition, 
McLean et al demonstrated the presence of variable proportions of monomeric, dimeric, 
trimeric Aβ species from the extracted samples of AD brain (McLean et al., 1999). 
Strikingly, also the number of spines dramatically decreases when neurons are grown in 
the presence of sub-nanomolar concentrations Aβ oligomer (Shankar et al., 2007). 
Furthermore, Shankar et al shows that human brains contain Aβ assemblies that eluted 
from size exclusion columns, and migrate on SDS polyacrylamide gels, with sizes of ~ 8 
kDa, and that these low-molecular weight oligomers can block LTP and impair memory 
consolidation (Shankar et al., 2008). This finding suggests that SDS-stable dimers may be 
basic building blocks of AD-associated synaptotoxic Aβ assemblies (Kuo et al., 1996; 
Roher et al., 1996)  
 
Previous studies demonstrated that (AβS26C)2 is a potent to neurotoxin (Hu et al., 2008; 
Shankar et al., 2008). It was further investigated whether this toxicity depended on 
aggregation, where it was found that (AβS26C)2 formed protofibril-like assemblies more 
rapidly than AβS26C or wild-type monomers (O’Nuallain et al., 2010). The protofibril-
like oligomers formed by (AβS26C)2 persisted longer, and potently inhibited long term 
potentiation (LTP) in mouse hippocampus (O’Nuallain et al., 2010). In addition, elevated 
levels of Aβ  dimers with  dityrosine cross-links have been observed in the hippocampus, 







Although there are several lines of evidence suggesting that non-fibrillar water-soluble 
forms of Aβ may underlie neurotoxicity in AD brain, structures of non-fibrillar Aβ still 
remain largely unidentified (Hardy and Selkoe, 2002; Klein et al., 2001, 2004). Structures 
of Aβ dimers may provide important clues about the basic building blocks of AD-
associated synaptotoxic assemblies. Previous structural studies using solid state NMR 
spectroscopy (SS-NMR) and electron microscopy showed various morphologies and 
structures of Aβ40 fibrils (Bertini et al., 2011; Paravastu et al., 2008; Petkova et al., 2006). 
However, several evidences suggested that toxicity was mediated by non-fibrillar 
components of Aβ (Chimon et al., 2007). Those species also had been found in human 
brain (Kokubo et al., 2005; Tomic et al., 2009). Here we present a study of the structures 
of Aβ [M1-40] monomer and two dimeric forms of Aβ [M1-40] in atomic details using 
NMR spectroscopy: [Aβ M(1-40)S26C]2, which has a covalent disulfide bond at position 
26, and [Aβ (M1-40)]dityr, which has a covalent bond at the side chain of tyrosine-10 
(Figure 4.3). Our results demonstrate that there is only a very slight difference in the 
structural propensities of the Aβ [Μ1−40] species, which display significantly distinct 
aggregation properties.    
 
Figure 4.3 Schematic representations of the bonds linking the monomers in (A) [Aβ(1-
40)]dityr and (B) [Aβ(1-40)S26C]2. 
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4.3 Material and Methods 
 
Reagents 
Unless otherwise stated, all chemical reagents were purchased from Sigma (Sigma-
Aldrich, St. Louis, MO) and were of the highest purity available. Water was purified using 
the Milli-Q Water Purification System (Millipore, Billerica, MA). Synthetic peptides, 
Aβ(1-40) (D A E F R H D S G Y E V H H Q K L V F F A E D V G S N K G A I I G L M 
VG G V V) and Aβ(1-40) in which serine-26 was substituted with cysteine, Aβ(1-
40)S26C,were synthesized, purified, and characterized by Dr. James I. Elliott at Yale 
University, (New Haven, CT). The peptide mass and purity were determined by 
electrospray/ ion trap mass spectrometry and purified by reverse phase HPLC. 
 
Recombinant Peptide Production: 
Recombinant Aβ(M1-40) and Aβ(M1-40)S26C were expressed and purified essentially as 
described previously (Walsh et al., 2009). pET vectors containing a gene beginning with 
“AUG” (start codon, methionine) followed by the full length Aβ sequence, for both Aβ(1-
40) wild type and serine-26 substituted for cysteine, Aβ(1-40)S26C, were used to 
transform Escherichia coli BL21* DE3 pLysS cells (Promega Biosciences, San 
LuisObispo, CA). Transformed cells were grown on LB Agar plates containing 50 μg/ml 
ampicillin and 38 μg/ml chloramphenicol as selecting antibiotics. A starter culture of a 
single colony produced was grown in 50 ml LB media containing selecting antibiotics by 
incubation at 37oC in a New Brunswick I-2500 orbital shaker and incubator (Eppendorf, 
Hauppauge, NY), rotating at 120 rpm overnight. 4 ml of overnight culture was used to 
inoculate 8x 400 ml of LB media in 2 L baffled flasks, which were incubated at 37oC with 
orbital shaking at 120 rpm. Optical density at 600 nm (OD600) was monitored every 45 
minutes on a SpectraMax M2 cuvette reader (Molecular Devices, Sunnyvale, CA) until a 
value of 0.6 was achieved. Peptide expression was induced by addition of IPTG to a final 
concentration of 0.4 mM and bacterial growth was continued until there was a steady 
plateau in OD600. Bacterial cells were collected by centrifugation at 4200 rpm in a 
Beckmann centrifuge (Beckmann Coulter, Indianapolis, IN) and 2 L pellets snap frozen in 
25 ml 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA. Pellets were thawed at room temperature 





followed by centrifugation at 18,000 g in a Sorvall RC5C Plus centrifuge with SS-150 
rotor (DuPont BioSciences), to isolate Aβ containing inclusion bodies. Inclusion bodies 
were solubilized by sonication in 15 ml 8 M Urea/ 10 mM Tris-HCl, pH 8.5/ 1 mM  EDTA 
and centrifugation as above. Supernatant of the centrifugation was diluted 1:4 with 10 mM 
Tris-HCl, pH 8.5/ 1 mM EDTA and applied to previously prepared Whatman DE23 anion-
exchange resin (Whatman cat. # 4053-025) and incubated at room temperature with 
rocking for 30 minutes. The resin bound Aβ was applied to a vacuum filter and washed 
with 2 x 25 ml 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA and 1 x 25ml 25mM NaCl/ 10 mM 
Tris-HCl, pH 8.5/ 1 mM EDTA. Aβ was eluted from anion-exchange resin by 6 sequential 
washes with 25 ml 125 mM NaCl/ 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA. Aβ elution was 
confirmed by SDS-PAGE with silver staining. Elution fractions were transferred to 3 kDa 
snakeskin dialysis tubing (Thermo Scientific cat. # 68035) and dialyzed against 3x 5 L 10 
mM ammonium bicarbonate, pH 8.5. Anion-exchange resin was regenerated by washing 
with 1x 25 ml 500 mM NaCl/ 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA followed by 8M 
Urea in 500 mM NaCl/ 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA and then removal of trace 
salts with washing and storage in 10 mM Tris-HCl, pH 8.5/ 1 mM EDTA, labelling resin 
container with respective Aβ peptide that was purified from it. Dialysed Aβ peptide was 
aliquoted to 6x 25 ml portions in 50 ml conical tubes, frozen and lyophilised on a 
FreezeZone 2.5 freeze drier (Labconco, Kansas City, MO). Lyophilisates of semi-purified 
bacterial extract were dissolved in 3 ml 7 M guanidine HCl/ 50 mM Tris-HCl, pH 8.5/ 5 
mM EDTA. In the case of Aβ(M1-40)S26C, crude bacterial extract was incubated with 
2.5% 2 mercaptoethanol to reduce disulfide crosslinking that may have occurred during 
dialysis. Semi-purified bacterial extract was further purified by gel filtration 
chromatography using a superdex 75 16/60 column (GE Healthcare Biosciences, 
Pittsburgh, PA) connected to a DuoFlow FPLC (Bio-Rad, Hercules, CA). Peptide was 
injected and eluted at 0.8 ml/ min in 50 mM ammonium bicarbonate, pH 8.5, collecting 0.6 
ml fractions using a BioFrac fraction collector (Bio- Rad, Hercules, CA). Peak fractions of 
peptide determined by UV chromatographic analysis at 280 nm, were collected, pooled 
and the concentration determined by UV absorbance at 275 nm. The average yield of 
peptide was approximately 8 mg/ L of culture, of which 5 mg of SEC isolated Aβ(1-40) 
was aliquoted to 0.5 mg portions and 27 mg was cross-linked to form [Aβ(1-40)]dityr. For 
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Aβ(1-40)S26C the yield was also approximately 8 mg/ L of culture and the entire 
monomer peak fraction collected was cross-linked. 
 
Isotopically labelled Aβ peptide: 
13C and 15N isotopically labelled peptide was produced as described above, in minimal 
media containing 13C-glucose and 15NH4Cl (Cambridge Isotope, Cambridge, MA) as 
described previously (Studier, 2005). 
 
Peptide quality control: 
20 μg samples of cross-linking raw materials and finished products were dissolved in 
either 200 μl 0.1% TFA/ 99.9% H2O or 1 x sample buffer and the purity determined by 
reverse phase HPLC and SDS-PAGE with silver-staining respectively. 20 μl of a 0.1 
mg/ml sample was injected onto a Capcell PAK CN UG120 C18-HPLC column (Shiseido, 
Tokyo, Japan) and eluted over 60 minutes with a 0% - 60% gradient of acetonitrile with 
0.1% TFA/ H2O on a Beckmann 128 HPLC system (Beckmann Coulter, Indianapolis, IN). 
10 μl of a 0.1 mg/ml solution was loaded onto a 16% SDS-PAGE and electrophoresed at 
125 V for 2 hours. Gels were visualized by silver stain. The peptide sequence was 
confirmed by MALDI-TOF mass determination. 1 μg samples were prepared in a sinapinc 
acid/ HCCA solution, acquired in linear mode at 20kV and run on a 4800 MALDI-
TOF/TOF. Spectra were produced from an average of approximately 1200 shots over a 
specific mass-range of 3 kDa to 10 kDa. 
 
Oxidative cross-linking: 
SEC isolated Aβ(1-40) or Aβ(M1-40) was diluted to 40 μM and incubated at 37oC 
overnight in the presence of 2.2 μM horseradish peroxidase (Thermo Scientific cat. 
#34190) and 250 μM H2O2 (Moir et al., 2005). Reduced Aβ(1-40)S26C monomer was 
diluted to 40 μM and incubated at room temperature with infusion of 95% oxygen (Airgas, 
Hingham, MA) for 5 minutes every 24 hours for 72 hours (O’Nuallain et al., 2010). For 
both dimer preparations, 25 μl samples of the reaction mixture were taken and analyzed by 
SDS-PAGE with silver staining for the presence of Aβ dimer. Following cross-linking, the 
reaction mixtures were frozen, lyophilized and re-dissolved in 3 ml 7 M guanidine HCl/ 50 





incubated overnight at room temperature. The dimer was then isolated by gel filtration 
chromatography on a superdex 75 16/60 column. Peak fractions of dimer were pooled and 
the concentration determined by UV absorbance. 1 mg and 3 mg aliquots of peptide were 
made for further biophysical characterization, frozen and lyophilized. 20 μg samples were 
also prepared for quality control analysis, frozen and lyophilized. 
 
Experimental peptide preparation: 
1 mg (low concentration Aβ experiments) or 3 mg (high concentration Aβ experiments) 
were dissolved in 0.5 ml 7 M guanidine HCl /50 mM Tris-HCl, pH 8.5/ 5 mM EDTA and 
incubated overnight at room temperature. Aβ monomer or dimer were isolated from 
aggregates by gel filtration chromatography by injection onto a superdex 75 30/300 
column (GE Healthcare Biosciences, Pittsburgh, PA) eluting at 0.5 ml/ min in desired 
experimental buffer. 
Concentration determination: 
1 mg of Aβ(1-40) or [Aβ(1-40)]dityr was dissolved in 0.5 ml 7M guanidine HCl/ 50 mM 
Tris-HCl, pH 8.5/ 5 mM EDTA and isolated from aggregates by gel filtration 
chromatography on a superdex 75 30/300 column (GE Healthcare Biosciences, Pittsburgh, 
PA) eluting in 20 mM sodium phosphate, pH 8.0. Peak fractions of both peptides were 
collected a sample transferred to a 200 μl, 1 cm quartz cuvette (Starna Scientific, Hainault, 
UK) and a UV scan performed between 240 nm and 320 nm on a SpectraMax M2 cuvette 
reader (Molecular Devices, Sunnyvale, CA). UV scans indicate the maximal wavelength 
(λmax) for Aβ(1-40) at 275 nm and [Aβ(1-40)]dityr at 283 nm. UV absorbance was 
recorded for Aβ(1-40) and [Aβ(1-40)]dityr at these respective wavelengths and a 20 μl 
sample of the peak fraction was transferred to a hydrolysis tubes in duplicate and sealed 
with parafilm. 180 μl of the peak fraction was diluted to 200 μl (90% of peak fraction), the 
absorbance recorded and a 20 μl sample transferred to a hydrolysis tube in duplicate. This 
was repeated for 80- 60% dilutions. Hydrolysis tube samples were frozen and lyophilized 
and hydrolyzed at 110oC in 6 M HCl for 24 hours. Concentrations of samples were 
determined by quantitative amino acid analysis and graphed against their UV absorbance. 
A curve forced through zero was plotted and the slope of the curve taken as the extinction 
coefficient (ε). 
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Thioflavin T Dye Binding Assay 
Aggregation of samples was monitored by continuous thioflavin T (ThT) dye binding 
assay. Samples were treated with 100 x (ThT) solution to yield a final concentration of 20 
μM ThT and 20 μM peptide solution. Dilutions of the sample were prepared using elution 
buffer containing 1 x ThT. 120 μl of each Aβ concentration to be analyzed were reverse-
pipetted into a black Nunc* non-treated, flat bottom, black 96 well plate (Fisher Scientific: 
#1256609) in 6 replicates. A blank (no peptide containing) sample was also prepared. The 
outer edge wells of the plate were filled with sample buffer and never used for sample 
analysis. At time zero (t = 0), plates were analyzed on a SpectraMax M2 microplate reader 
(Molecular Devices, Sunnyvale, CA) with excitation at 435nm and emission read at 
485nm. The samples were homogenized in wells with 5 seconds of shaking before 
readings. Plates were then covered with a 96 well plate cover slip and incubated at 37oC 
with shaking at 700 RPM on a WorTemp 56 incubator/ shaker with an orbit of 3 mm 
(Labnet International, Windsor, UK). Readings were taken every 20 minutes for 3 hours 
and then at defined times thereafter. Data is presented as relative fluorescence units plotted 
against time in hours. Curves were produced by point-to-point connecting lines with no 
curve fit. The lag time was defined as the first time point showing a statistically significant 
increase (Student T-test) in fluorescence compared to the t = 0 hours reading, the rate of 
aggregation is calculated from the slope of the linear aggregation phase and the point of 
heterogeneous species mixture 
 
Negative stain Transmission Electron Microscopy (TEM): 
10 μl of TEM samples (samples were incubated at 37oC with shaking minus ThT) were 
applied to a carbon-coated Formvar grid for one minute before cross-linking sample to the 
grid using 10 μl 0.5% TEM grade gluteraldehyde. Grids were washed gently with MQ H2O 
and stained for two minutes with 2% urnyl acetate (Electron Microscope Sciences, Fort 
Washington, PA), blotted dry and further air dried under cover. All TEM samples were 
prepared in duplicate and electron micrographs visualized on a Technai G2 
SpiritBioTWIN electron microscope (FEI, Hillsboro, OR). TEM grids were scanned in a 
serpentine fashion at a relatively low magnification (~12000 x), noting the abundance of 







Isotopically labeled U-[13C,15N] Aβ(M1-40) monomer, dimer [Aβ(M1-40)S26C]2 and 
[Aβ(M1-40)]tyr were eluted fresh from size exclusion chromatography, and  prepared for 
NMR measurement at ~ 200 µM in 25 mM ammonium bicarbonate buffer pH 8. NMR 
samples included 28 µL of 1.5 mM DSS in D2O. 
 
All NMR experiments were carried out on a Varian Unity INOVA 600 MHz spectrometer 
equipped with a pulsed field gradient probe. The spectra were recorded at 278 K. 2D and 
3D NMR experiments were performed to obtain backbone and side chain assignment. The 
list of NMR measurements is shown in Table 1 
 






















15N 1650 119.288 77.6 
1 h 17'   




13C 10000 43.3261 20 
1h 15'   




13C 1500 174 133 
7h 55'   




1H 8000 5.028 64 
7h43'   




1H 8000 5.028 64 
16h19'   15N 1650.01 119.28 24.2 




1H 8000 5.028 64 
16h17'   15N 1650 119.28 24.2 
13C 3920 56 10 
1D 128  1H  8000  5.028 1  5’ 
 
The raw data from 2D and 3D NMR experiments were processed using NMRPipe 
(Delaglio et al., 1995) and the obtained spectra were analyzed using Sparky (Goddard and 
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Kneller, 2008). All chemical shifts were referenced to DSS based on IUPAC 
recommendation (Markley et al., 1998).  
 
4.4 Results  
We compared the aggregation properties of three species of Aβ(1-40): Monomer Aβ(1-40), 
dimer [Aβ(1-40)S26C]2 and dimer [Aβ(1-40)]dityr.. Our data shows that  for [Aβ(1-
40)S26C]2, the ThT fluorescence signal increased rapidly without any measurable lag time 
and reached its plateau after ~70 h. In contrast, there was no appreciable increase in ThT 
signal for Aβ(1-40) and [Aβ(1-40)]dityr over the same time period. The aggregation kinetics 
data for [Aβ(1-40)S26C]2  is found to be  in a good agreement with a previous report  
(O’Nuallain et al., 2010). 
 
Figure 4.4: [Aβ(1-40)S26C]2, but not Aβ(1-40) or [Aβ(1-40)]dityr, readily aggregates under 
quiescent conditions. SEC-isolated Aβ(1-40) ( ), [Aβ(1-40)]dityr ( ) and [Aβ(1-40)S26C]2 
( ) were diluted to 20 µM with SEC elution buffer, 20 mM sodium phosphate pH 8.0, combined 
with 20 µM thioflavin T and incubated at 37oC. As a control, buffer alone ( ) was also 
analysed. ThT fluorescence was measured at regular intervals. 
 
Next, we investigated the aggregation properties of Aβ(1-40) monomer and dimer, when 
they were shaken and incubated at 37oC in the same pH and buffer condition. The 





plateau after less than 2 hours (Figure 4.5 A). Interestingly, dimer [Aβ(1-40)]dityr, 
aggregates even more slowly than monomer Aβ(1-40) since its fluorescence signal 
intensity reaches log time  after 15-20 hours. The opposite results were found for dimer 
[Aβ(1-40)S26C]2 ,  where there is no appreciable lag time and it reaches its plateau after 20 
hours with higher fluorescence signal intensity. When end-point samples were used for 




Figure 4.5: Aβ(1-40), [Aβ(1-40)]dityr and [Aβ(1-40)S26C]2 aggregate at different 
rates and form different products. (A) 2.5 – 40 μM of SEC-isolated Aβ(1-40), [Aβ(1-
40)]dityr or [Aβ(1-40)S26C]2 in sodium phosphate, pH 8.0, were combined with 20 μM ThT. 
Samples were incubated at 37oC with shaking and ThT fluorescence monitored at regular intervals. 
Each point is the average of 6 replicates +/- standard error of the mean. Curves were generated by a 
point-to-point line and for some points the error is smaller than the symbol. The results shown are 
representative of at least 3 independent experiments. (B) End-point samples incubated in the 
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The conformational details of monomeric and dimeric of Aβ(M1-40 were studied by NMR 
spectroscopy. Nearly complete backbone assignment of Cα, Hα, N, C’ for Aβ(M1-40), 
[Aβ ([M1-40)S26C]2 and [Aβ (M1-40)]dityr at pH 8 have been obtained using 2D and 3D 
NMR experiments (see SI). The assignment approach taken here at pH 8.0 relies mainly on 
the observation of Hα protons, as most backbone amide signals are broadened beyond 
detection by exchange with solvent.  
               
 
Figure 4.6. The spectra of covalent dimers of Aβ(M1-40) are remarkably similar to the 
monomeric form. Overlay of 2D 13C-1H aliphatic HSQC on the Cα-Hα region of Aβ(M1-40) (red) 
with (A) [Aβ(M1-40)]dityr  (green) and (B) [Aβ(M1-40)S26C]2 (blue). 
 
Figure 4.6 shows a comparison of 2D 13C-1H aliphatic HSQC spectra for monomer 
[Aβ(M1-40)] and covalent [Aβ(M1-40)] dimers. [Aβ(M1-40)S26C]2 and [Aβ(M1-40)]dityr 
NMR spectra overlay very well with that of the monomer Aβ(M1-40), except for some 
local changes that affect only a few residues. Since the Cα chemical shift is very sensitive 
to secondary structure changes, Figure 4.6 allows conclusions to be drawn about structural 





indicate that the covalent dimers are also intrinsically disordered, and that covalent 
modification only marginally affects their average structures in solution. This result is 
consistent with a previous study that utilized circular dichroism  (CD) spectroscopy to 
obtain the secondary structure content of (AβS26C)2 (O’Nuallain et al., 2010) 
residue numberresidue number residue numberresidue number
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Figure 4.7 Di-tyrosine and di-cysteine dimers of Aβ(M1-40) remain intrinsically 
disordered, and demonstrate opposite propensities for secondary structure contents. 
Structural propensity of Aβ(M1-40) (A), [Aβ(M1-40)]dityr (B) [Aβ(M1-40)S26C]2  (C) at pH 8 
based on Cα, Hα, N, and C’ backbone chemical shifts, and compared with Aβ(1–40) in complex 
with the affibody ZAβ3 (12–58). The structural propensity for every backbone chemical shifts was 
determined using the neighbor-corrected structural propensity calculator ncSPC (Tamiola and 
Mulder, 2012).  Resonance assignments for the complex of Aβ(1–40) with ZAβ3  were taken from the 
BioMagResBank repository (BMRB ID 17159). 
 
In recent studies, it has been known that the affibody ZAβ3 is capable of dissolving 
preformed Aβ oligomers (Luheshi et al., 2010; Sandberg et al., 2010) and also can prevent 
Aβ from aggregation (Lindgren et al., 2010). Sandberg and co-workers showed that the β-
hairpin conformation of Aβ40 was observed in complex with ZAβ3 and this conformation is 
very similar to a model of the AβA21C/A30C double mutant (AβCC), in which the β-
hairpin conformation is locked by a disulfide bond. They showed that this β-hairpin 
conformation mediates Aβ toxicity (Sandberg et al., 2010).  
 
However, when our 13Cα, 15N, 1Hα, 13C’ chemical shifts data were translated into 
structural propensities using neighbor corrected structural propensity (ncSPC) calculations 
(Figure 4.7) (Tamiola and Mulder, 2012), we observed that the structural propensity of 
Aβ(1–40) in complex with ZAβ3 is very different from the structural propensities of 
monomer Aβ(M1-40) and the [Aβ(M1-40)]dityr and [Aβ(M1-40)S26C]2. Both Aβ(M1-40) 
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dimers remain unstructured, and their structural propensities are very similar to that of 
monomer Aβ(M1-40), with the exception of several small deviations. The covalent link 
introduced at the Tyr-10 side chain leads to a slight increase of helical propensity around 
position 10, but it does not affect the beta sheet propensity of the regions that are known to 
form the core of Aβ amyloid fibril structures (Bertini et al., 2011; Tycko, 2011). In 
contrast, the introduction of a disulfide bond at residue 26 in [Aβ(M1-40)S26C]2 leads to a 
small, but observable, increase in beta-sheet propensity, especially within the first region 
(residue 16-24). 
 
Figure 4.8.  Covalent dimerization at tyrosine-10 leads to marginal and strictly local 
structural changes, while covalent dimerization at cysteine-26 leads to marginal structural 
changes, which extend beyond the point of attachment. Chemical shift differences (Δδ) between 
[Aβ(M1-40)]dityr and Aβ(M1-40) observed for (A) 1Hα, (B) 13Cα and (C) 13C’ and between [Aβ(M1-
40)S26C]2 and Aβ(M1-40) observed for (D) 1Hα, (E) 13Cα and (F) 13C’ at pH 8.0. Chemical shift 
differences between  [Aβ(M1-40)]dityr and Aβ(M1-40) are calculated as Δδ = δ[Aβ(M1-40)]dityr - 
δ[Aβ(M1-40)] and chemical shift differences between  [Aβ(M1-40)S26C]2 and Aβ(M1-40) are 
calculated as Δδ = δ[Aβ(M1-40)S26C]2 - δ[Aβ(M1-40)].  
 
Careful examination of the chemical shift difference between [Aβ(M1-40)]dityr  and  
Aβ(M1-40), and also between [Aβ(M1-40)S26C]2  and  Aβ(M1-40) were carried out based 





between [Aβ(M1-40)]dityr  and  Aβ(M1-40) are limited to residues 8 to 13 (Figure 4.8 A-C). 
Changes in backbone dihedral angles lead to chemical shift differences (spectral peak 
position) for backbone nuclei. A decrease in beta sheet propensity or an increase in alpha-
helical content will manifest itself in decreased values for 1Hα, whereas the opposite trend 
is observed for 13Cα and 13C'. 
 
In contrast, significant chemical shift differences between [Aβ(M1-40)S26C]2 and Aβ(M1-
40) are found for the region around residue 26 (from residue 23 to 27), but also for the 
more remote part, residues 16 to 20 (Figure 4.7 D-F). The longer-range changes in 
chemical shifts that are observed for this region suggests that the disulfide linkage 
modulates the structural propensity in distant parts of the sequence. Yet, also in this case 
the changes are very limited, and the secondary structure content outside the immediate 
region around the cystine bridge is altered by only a small fraction. 
 
Next, we analyzed the signal intensities in the 2D NMR spectra for monomer and dimeric 
peptides, as these can be used to qualitatively probe dynamics changes: Motional 
restriction will lead to reduced signal intensities in constant-time 13C-1H HSQC 
experiment, due to increased T2 relaxation., As shown in Figure 4.9, we observed very low 
signal intensity around the attachment point for both [Aβ(M1-40)]tyr and [Aβ(M1-
40)S26C]2. Clearly, the introduction of covalent bonds for Aβ dimer formation limits chain 
mobility arround the attachment point. 
 
 
Figure 4.9. Covalent dimer formation restricts chain mobility around the attachment point. 
Cα-Hα cross-peak signal intensities for Aβ(M1-40) (A), [Aβ(M1-40)]dityr (B) and [Aβ(M1-
40)S26C]2  (C) at pH 8, in 13C-1H HSQC spectra. 
 




Small differences in structural propensities of dimeric forms of Aβ(M1-40) correlates 
with differences in aggregation properties.   
We performed here structural studies of monomer Aβ(M1-40) and two dimers of Aβ(M1-
40), which are covalently linked at position 10 and 26, in relation with their aggregation 
properties. Our data demonstrate that the introduction of different covalent bonds to form 
dimeric Aβ(M1-40) correlates with altered kinetics of fibril formation. Interestingly, we 
found that the dityrosine dimer of Aβ(M1-40) does not exhibit rapid aggregation and the 
introduction of covalent bond at the side chain of Tyr-10 induces only slight impacts on 
the helical propensities from residue 8 to 13, but does not affect beta sheet propensities. On 
the other hand, different results were found when we compare with (Aβ(M1-40)S26C)2, 
which show very rapid aggregation kinetics, even under quiescent condition. Our NMR 
data shows only a slight increase in beta sheet propensity for the first region (16-24). 
These data suggest that possibly, beta-sheet propensity in first region (residue 16-24) can 
accelerate the aggregation kinetic of fibril formation. The result presented here is similar to 
the result from an investigation of the conformational ensembles of monomeric Aβ40 and 
Aβ42 peptides (Ball et al., 2013). Although the difference between these two peptides is 
only two additional hydrophobic amino acid residues at the C-terminus in Aβ42, the two 
peptides have significantly different aggregation properties and toxicities. Several studies 
have demonstrated that Aβ42 aggregates much faster in vitro than Aβ40 (Hasegawa et al., 
1999; Jarrett et al., 1993)) and causes more extensive damage in neuronal cells (Dahlgren 
et al., 2002; Gravina et al., 1995; Roher et al., 1996). In the structural studies performed by 
Ball A.K et al, they showed that the proton and carbon chemical shifts also do not differ 
significantly from random coil values, and that J-coupling values are similar values for the 
two peptides. However, based on  MD simulation data, refined with the ENSEMBLE 
method and validated with NMR data, they showed that the most significant difference in 
structural ensembles of both peptides is the type of β structures they populate (Ball et al., 
2013). As several studies have shown that beta sheets form the core of amyloid fibrils 






The fact that ([Aβ(M1-40)]S26C)2 aggregates very rapidly suggests that the introduction of 
a covalent disulfide bond in the turn region might be sufficient to increase beta sheet 
propensity for the region 16-20 containing several hydrophobic side chains, and thereby 
increase the beta sheet propensity for the entire peptide. In contrast, increasing helical 
propensity in the region around Tyr-10 seems to slow down the aggregation kinetics. 
 
Previous study demonstrated that the predominant morphology in Aβ (1−40) samples can 
be affected by subtle changes in growth conditions, for example the presence or the 
absence of gentle agitation of the Aβ peptide solution during the fibril formation (Petkova 
et al., 2005). However, without changing the growth conditions, we found that the small 
structural propensity differences among monomer and dimers Aβ(M1-40) does not solely 
influence the aggregation kinetic, but also fiber morphology (Figure 4.6). Our finding 
suggests that slight difference in structural propensity of Aβ dimer may also cause 
different fiber morphology.  
 
Several studies have shown that soluble non-fibrillar Aβ can produce higher levels of 
toxicity on per basis molecule rather than mature fibril, which is also found to be 
correlated with cognitive impairment (Chimon et al., 2007; Hardy and Selkoe, 2002). The 
presence of dimer [Aβ(M1-40)tyr] has been found in the brain of patients with AD 
(Hensley et al., 1998), although it is still unclear whether this dimer causes Aβ toxicity or 
not.  Our results show that this dimer aggregates more slowly than Aβ [Μ1−40] monomer 
and displays a slightly more helical structural propensity in the region. In the case of 
(AβS26C)2, a previous work has examined carefully that this dimer aggregates rapidly to 
form protofibril-like assemblies and can inhibit LTP (O’Nuallain et al., 2010).  In the latter 
study, it was also suggested that (AβS26C)2 is a potent mediator of Aβ toxicity.  Here, we 
found that [Aβ(M1-40)S26C]2 remains disordered, and only a slight increase in beta sheet 
propensity is observed. This result is different from the covalently modified Aβ structure 
determined by Sandberg et al. They showed that the β-hairpin conformation can be locked 
by a disulfide bond (AβA21C/A30C), to form a structured dimer with strong beta sheet 
propensity (cf. Figure 4.7), which may well mediate Aβ toxicity (Sandberg et al., 2010). 
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However, our result clearly suggest that it may already be sufficient to slightly modulate 
structural propensities of the unstructured Aβ dimer in the initial phase, and thereby 
already affect Aβ toxicity. 
 
4.6 Conclusion 
In this study, we showed the aggregation properties of monomeric and two dimeric forms 
of Aβ (Μ1−40):  [Aβ(M1-40)tyr], which has covalent link at side chain of Tyr-10 and 
(Aβ(M1-40)S26C)2, which has disulfide bond at side chain of Cys-26. The former peptide 
exhibits slower aggregation kinetics compared to monomer, while the latter aggregates 
very rapidly even under quiescent conditions. The three peptides form different aggregates, 
as characterized by TEM, where different form fibrils were obtained. Structural studies 
using NMR spectroscopy demonstrate that [Aβ(M1-40)tyr] and (Aβ(M1-40)S26C)2 are 
both disordered, with only slight differences in their structural propensities. [Aβ(M1-40)tyr] 
displays slightly higher helical propensities in the region 8-13, while (Aβ(M1-40)S26C)2  
exhibits slightly increased beta sheet propensities from residue 23 up to 27 and also from 
residue 16 to 20. The fact that the differences in structural propensities of those peptides 
are quite marginal, suggests that it might be sufficient to only slightly modulate the 




Ball, K.A., Phillips, A.H., Wemmer, D.E., and Head-Gordon, T. (2013). Differences in β-
strand populations of monomeric Aβ40 and Aβ42. Biophys. J. 104, 2714–2724. 
Bertini, I., Gonnelli, L., Luchinat, C., Mao, J., and Nesi, A. (2011). A new structural model 
of Aβ40 fibrils. J. Am. Chem. Soc. 133, 16013–16022. 
Busciglio, J., Lorenzo, A., and Yankner, B.A. (1992). Methodological variables in the 
assessment of beta amyloid neurotoxicity. Neurobiology of Aging 13, 609–612. 
Chimon, S., Shaibat, M.A., Jones, C.R., Calero, D.C., Aizezi, B., and Ishii, Y. (2007). 
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of 





Dahlgren, K.N., Manelli, A.M., Stine, W.B., Jr, Baker, L.K., Krafft, G.A., and LaDu, M.J. 
(2002). Oligomeric and fibrillar species of amyloid-beta peptides differentially affect 
neuronal viability. J. Biol. Chem. 277, 32046–32053. 
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995). 
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. 
Biomol. NMR 6, 277–293. 
Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B.A. (1998). Aging 
renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4, 827–831. 
Goddard, T., and Kneller, D. (2008). SPARKY. 
Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L., Jr, Younkin, L.H., Suzuki, N., 
and Younkin, S.G. (1995). Amyloid beta protein (A beta) in Alzheimer’s disease brain. 
Biochemical and immunocytochemical analysis with antibodies specific for forms ending 
at A beta 40 or A beta 42(43). J. Biol. Chem. 270, 7013–7016. 
Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, 
B.L., Lieberburg, I., Koo, E.H., Schenk, D., and Teplow, D.B. (1992). Amyloid beta-
peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325. 
Hardy, J., and Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer’s disease: 
progress and problems on the road to therapeutics. Science 297, 353–356. 
Hasegawa, K., Yamaguchi, I., Omata, S., Gejyo, F., and Naiki, H. (1999). Interaction 
between A beta(1-42) and A beta(1-40) in Alzheimer’s beta-amyloid fibril formation in 
vitro. Biochemistry 38, 15514–15521. 
Hensley, K., Maidt, M.L., Yu, Z., Sang, H., Markesbery, W.R., and Floyd, R.A. (1998). 
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain 
indicates region-specific accumulation. J. Neurosci. 18, 8126–8132. 
Hu, N.-W., Smith, I.M., Walsh, D.M., and Rowan, M.J. (2008). Soluble amyloid-beta 
peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular 
dysfunction in vivo. Brain 131, 2414–2424. 
Jarrett, J.T., Berger, E.P., and Lansbury, P.T., Jr (1993). The carboxy terminus of the beta 
amyloid protein is critical for the seeding of amyloid formation: implications for the 
pathogenesis of Alzheimer’s disease. Biochemistry 32, 4693–4697. 
Katzman, R. (1986). Alzheimer’s disease. N. Engl. J. Med. 314, 964–973. 
Klein, W.L., Krafft, G.A., and Finch, C.E. (2001). Targeting small Abeta oligomers: the 
solution to an Alzheimer’s disease conundrum? Trends Neurosci. 24, 219–224. 
Disordered covalent Aβ dimers with different aggregation properties 
 
 121 
Klein, W.L., Stine, W.B., Jr, and Teplow, D.B. (2004). Small assemblies of unmodified 
amyloid beta-protein are the proximate neurotoxin in Alzheimer’s disease. Neurobiol. 
Aging 25, 569–580. 
Kokubo, H., Kayed, R., Glabe, C.G., and Yamaguchi, H. (2005). Soluble Abeta oligomers 
ultrastructurally localize to cell processes and might be related to synaptic dysfunction in 
Alzheimer’s disease brain. Brain Res. 1031, 222–228. 
Kuo, W.L., Gehm, B.D., and Rosner, M.R. (1990). Cloning and expression of the cDNA 
for a Drosophila insulin-degrading enzyme. Mol. Endocrinol. 4, 1580–1591. 
Kuo, Y.M., Emmerling, M.R., Vigo-Pelfrey, C., Kasunic, T.C., Kirkpatrick, J.B., 
Murdoch, G.H., Ball, M.J., and Roher, A.E. (1996). Water-soluble Abeta (N-40, N-42) 
oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077–4081. 
Lindgren, J., Wahlstrom, A., Danielsson, J., Markova, N., Ekblad, C., Graslund, A., 
Abrahmsen, L., Karlstrom, A.E., and Warmlander, S.K. (2010). N-terminal engineering of 
amyloid-?-binding Affibody molecules yields improved chemical synthesis and higher 
binding affinity. Protein Sci 19, 2319–2329. 
Lue, L.F., Kuo, Y.M., Roher, A.E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J.H., 
Rydel, R.E., and Rogers, J. (1999). Soluble amyloid beta peptide concentration as a 
predictor of synaptic change in Alzheimer’s disease. Am. J. Pathol. 155, 853–862. 
Luheshi, L.M., Hoyer, W., de Barros, T.P., van Dijk Hard, I., Brorsson, A.-C., Macao, B., 
Persson, C., Crowther, D.C., Lomas, D.A., Stahl, S., et al. (2010). Sequestration of the A? 
Peptide Prevents Toxicity and Promotes Degradation In Vivo. PLoS Biol 8. 
Markley, J.L., Bax, A., Arata, Y., Hilbers, C.W., Kaptein, R., Sykes, B.D., Wright, P.E., 
and Wüthrich, K. (1998). Recommendations for the presentation of NMR structures of 
proteins and nucleic acids--IUPAC-IUBMB-IUPAB Inter-Union Task Group on the 
standardization of data bases of protein and nucleic acid structures determined by NMR 
spectroscopy. Eur. J. Biochem. 256, 1–15. 
McLean, C.A., Cherny, R.A., Fraser, F.W., Fuller, S.J., Smith, M.J., Beyreuther, K., Bush, 
A.I., and Masters, C.L. (1999). Soluble pool of Abeta amyloid as a determinant of severity 
of neurodegeneration in Alzheimer’s disease. Ann. Neurol. 46, 860–866. 
Moir, R.D., Tseitlin, K.A., Soscia, S., Hyman, B.T., Irizarry, M.C., and Tanzi, R.E. (2005). 
Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of 
Alzheimer’s disease patients. J. Biol. Chem. 280, 17458–17463. 
O’Nuallain, B., Freir, D.B., Nicoll, A.J., Risse, E., Ferguson, N., Herron, C.E., Collinge, J., 
and Walsh, D.M. (2010). Amyloid beta-protein dimers rapidly form stable synaptotoxic 





Paravastu, A.K., Leapman, R.D., Yau, W.-M., and Tycko, R. (2008). Molecular structural 
basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 
105, 18349–18354. 
Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.-M., Mattson, M.P., and Tycko, R. 
(2005). Self-Propagating, Molecular-Level Polymorphism in Alzheimer’s ß-Amyloid 
Fibrils. Science 307, 262–265. 
Petkova, A.T., Yau, W.-M., and Tycko, R. (2006). Experimental constraints on quaternary 
structure in Alzheimer’s beta-amyloid fibrils. Biochemistry 45, 498–512. 
Pike, C.J., Walencewicz, A.J., Glabe, C.G., and Cotman, C.W. (1991). In vitro aging of 
beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311–
314. 
Roher, A.E., Chaney, M.O., Kuo, Y.M., Webster, S.D., Stine, W.B., Haverkamp, L.J., 
Woods, A.S., Cotter, R.J., Tuohy, J.M., Krafft, G.A., et al. (1996). Morphology and 
toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of 
Alzheimer’s disease. J. Biol. Chem. 271, 20631–20635. 
Sandberg, A., Luheshi, L.M., Söllvander, S., Barros, T.P. de, Macao, B., Knowles, T.P.J., 
Biverstål, H., Lendel, C., Ekholm-Petterson, F., Dubnovitsky, A., et al. (2010). 
Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering. PNAS 
107, 15595–15600. 
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., 
Schlossmacher, M., Whaley, J., and Swindlehurst, C. (1992). Isolation and quantification 
of soluble Alzheimer’s beta-peptide from biological fluids. Nature 359, 325–327. 
Shankar, G.M., and Walsh, D.M. (2009). Alzheimer’s disease: synaptic dysfunction and 
Abeta. Mol Neurodegener 4, 48. 
Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J., and Sabatini, 
B.L. (2007). Natural oligomers of the Alzheimer amyloid-beta protein induce reversible 
synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling 
pathway. J. Neurosci. 27, 2866–2875. 
Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, 
F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., et al. (2008). Amyloid-beta protein 
dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. 
Nat. Med. 14, 837–842. 
Shoji, M., Golde, T.E., Ghiso, J., Cheung, T.T., Estus, S., Shaffer, L.M., Cai, X.D., 
McKay, D.M., Tintner, R., and Frangione, B. (1992). Production of the Alzheimer amyloid 
beta protein by normal proteolytic processing. Science 258, 126–129. 
Studier, F.W. (2005). Protein production by auto-induction in high density shaking 
cultures. Protein Expr. Purif. 41, 207–234. 
Disordered covalent Aβ dimers with different aggregation properties 
 
 123 
Tamiola, K., and Mulder, F.A.A. (2012). Using NMR chemical shifts to calculate the 
propensity for structural order and disorder in proteins. Biochem. Soc. Trans. 40, 1014–
1020. 
Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., 
and Katzman, R. (1991). Physical basis of cognitive alterations in Alzheimer’s disease: 
synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580. 
Tomic, J.L., Pensalfini, A., Head, E., and Glabe, C.G. (2009). Soluble fibrillar oligomer 
levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction. 
Neurobiol. Dis. 35, 352–358. 
Tycko, R. (2011). Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys 
Chem 62, 279–299. 
Walsh, D.M., and Selkoe, D.J. (2007). A beta oligomers - a decade of discovery. J. 
Neurochem. 101, 1172–1184. 
Walsh, D.M., Klyubin, I., Shankar, G.M., Townsend, M., Fadeeva, J.V., Betts, V., 
Podlisny, M.B., Cleary, J.P., Ashe, K.H., Rowan, M.J., et al. (2005). The role of cell-
derived oligomers of Abeta in Alzheimer’s disease and avenues for therapeutic 
intervention. Biochem. Soc. Trans. 33, 1087–1090. 
Walsh, D.M., Thulin, E., Minogue, A.M., Gustavsson, N., Pang, E., Teplow, D.B., and 
Linse, S. (2009). A facile method for expression and purification of the Alzheimer’s 
disease-associated amyloid beta-peptide. FEBS J. 276, 1266–1281. 
Wang, J., Dickson, D.W., Trojanowski, J.Q., and Lee, V.M. (1999). The levels of soluble 
versus insoluble brain Abeta distinguish Alzheimer’s disease from normal and pathologic 

















Resonance list of Aβ(M1-40) monomer at pH 8 and temperature 278 K 
 
Residue HN Cα Hα C NH 
M0              55.829 3.64 178.255 42.447 
D1                54.315 4.575 176.16 
A2 52.794 4.228 177.763 
E3 56.514 4.167 176.13 
F4 8.296 57.835 4.489 175.3 121.427 
R5 55.629 4.245 
H6 56.652 4.542 174.794 
D7 53.984 4.592 176.358 121.839 
S8 59.066 4.351 175.193 116.804 
G9 45.336 3.86 174.096 110.791 
Y10 8.041 58.055 4.512 175.752 120.156 
E11 8.488 56.9 4.105 176.198 122.754 
V12 8.203 62.785 3.918 176.072 121.282 
H13 56.502 4.555 
H14 56.848 4.456 
Q15 55.851 4.237 
K16 56.324 4.257 176.322 
L17 8.349 55.097 4.312 176.846 123.938 
V18 8.111 61.938 4.01 175.185 121.772 
F19 8.384 57.331 4.567 174.789 124.706 
F20 8.341 57.286 4.559 174.737 123.31 
A21 8.357 52.298 4.202 177.295 126.429 
E22 8.472 56.569 4.188 176.284 120.18 
D23 8.532 54.062 4.631 176.624 122.081 
V24 8.27 62.734 4.123 177.123 120.88 
G25 8.66 45.477 3.981 174.566 111.972 
S26 
 




53.254 4.723 175.497 120.675 
K28 56.669 4.258 177.214 121.972 
G29 45.086 3.923 173.776 
A30 52.389 4.296 177.672 
I31 8.306 61.052 4.136 176.471 121.022 
I32 8.42 61.063 4.141 176.719 126.66 
G33 8.594 45.156 3.928 173.704 113.326 
L34 8.178 55.064 4.328 177.359 121.855 
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M35 55.207 4.517 176.194 122.281 
V36 8.376 62.486 4.116 176.732 122.772 
G37 45.2 3.966 174.489 113.35 
G38 45.037 3.969 173.722 
V39 8.197 62.421 4.161 175.605 120.138 





Resonance list of (Aβ(M1-40)S26C)2 at pH 8 and temperature 278 K 
 
Residue HN Cα Hα C NH 
M0 55.818 3.642 178.205 42.452 
D1 54.334 4.594 176.153 
A2 8.568 52.797 4.227 177.776 124.721 
E3 8.476 56.582 4.175 176.16  
119.707 
F4 8.299 57.863 4.536 175.317 121.671 
R5 8.122 55.885 4.248 175.643 124.009 
H6 8.455 56.664 4.502 121.624 
D7 53.967 4.591 121.855 
S8 8.519 59.048 4.35 175.219 116.808 
G9 8.608 45.283 3.871 174.041 110.813 
Y10 58.117 4.511 175.763 120.145 
E11 8.485 56.9 4.105 176.262 122.762 
V12 8.2 62.734 3.933 176.055 121.312 
H13 8.305 56.471 4.561 123.036 
H14 8.409 56.836 4.464 121.871 
Q15 55.798 4.254 175.51 
K16 8.015 56.321 4.264 176.281 123.391 
L17 8.344 55.036 4.325 176.84 123.938 
V18 8.109 61.842 4.029 175.13 121.643 
F19 8.373 57.289 4.578 174.872 124.484 
F20 8.372 57.274 4.568 174.847 123.012 
A21 8.372 52.337 4.216 177.315 126.258 
E22 8.482 56.595 4.351 176.206 120.016 
D23 8.508 54.132 4.619 176.38 121.783 
V24 8.197 62.613 4.127 176.87 120.728 
G25 8.618 45.343 3.951 174.361 111.389 





N27 8.736 53.363 4.713 175.254 120.44 
K28 8.44 56.651 4.264 177.175 123.984 
G29 8.544 45.098 3.912 173.718 109.647 
A30 8.144 52.341 4.304 177.649 123.672 
I31 8.29 60.999 4.145 176.483 120.886 
I32 8.403 61.16 4.153 176.714 126.436 
G33 8.571 45.173 3.929 173.717 113.163 
L34 8.165 55.111 4.335 177.374 121.814 
M35 8.557 55.201 4.499 176.221 122.185 
V36 8.368 62.472 4.12 176.731 122.645 
G37 8.71 45.163 3.979 174.511 113.308 
G38 8.363 45.089 3.974 173.745 108.841 
V39 8.193 62.411 4.168 175.628 120.102 
 V40 7.938 63.697 4.039 181.055 128.638 
 
 
Resonance list of [Aβ(M1-40)]dityr at pH 8 and temperature 278 K 
 
Residue HN Cα Hα C NH 
M0 55.787 3.656 177.998 42.475 
D1 54.343 4.592 176.114 123.952 
A2 8.552 52.74 4.227 177.725 124.681 
E3 8.47 56.509 4.172 176.121 119.756 
F4 8.295 57.788 4.513 175.293 121.634 
R5 8.148 55.978 4.204 124.022 
H6 56.805 4.486 175.483 
D7 8.425 54.045 4.572 176.362 122.004 
S8 8.477 58.932 4.33 175.161 116.722 
G9 8.586 45.501 3.847 110.769 
Y10 8.105 58.13 4.474 175.949 120.459 
E11 56.9 4.181 176.421 
V12 8.119 62.911 3.836 176.234 120.915 
H13 8.231 56.252 4.523 122.758 
H14 56.787 4.466 
Q15 55.87 4.231 
K16 56.334 4.233 176.412 
L17 8.287 55.113 4.316 176.92 123.663 
V18 8.095 61.922 4.008 175.258 121.672 
F19 8.358 57.355 4.57 174.897 124.579 
F20 8.334 57.341 4.558 174.819 123.198 
Disordered covalent Aβ dimers with different aggregation properties 
 
 127 
A21 8.327 52.283 4.203 177.319 126.396 
E22 8.456 56.515 4.169 176.186 120.258 
D23 8.54 54.067 4.629 176.69 122.056 
V24 8.276 62.773 4.117 177.181 120.993 
G25 8.649 45.418 3.968 174.516 111.916 
S26 8.177 58.518 4.411 174.55 116.257 
N27 53.256 4.721 175.549 120.655 
K28 56.684 4.255 177.275 
G29 8.521 45.127 3.924 173.782 109.702 
A30 8.128 52.378 4.29 177.722 123.726 
I31 8.3 61.045 4.134 176.521 121.026 
I32 8.408 61.121 4.137 176.724 126.611 
G33 8.59 45.072 3.918 173.761 113.38 
L34 8.167 55.066 4.328 177.389 121.848 
M35 8.562 55.195 4.516 176.245 122.266 
V36 8.366 62.526 4.112 176.778 122.745 
G37 8.722 45.174 3.969 174.53 113.368 
G38 8.36 45.175 3.972 173.769 108.844 
V39 8.191 62.427 4.163 175.658 120.137 
 V40 7.938 63.721 4.038 181.089 128.678 
  
 
